| Title : Treatment Duration of Cholinesterase Inhibitor Formulations in Alzheimer's Disease - Sato_2026_J.Am.Med.Dir.Assoc_27_106481 |
| Author(s) : Sato S , Sasabuchi Y , Yamana H , Kohro T , Yasunaga H |
| Ref : J Am Med Dir Assoc , 27 :106481 , 2026 |
| Abstract : |
| PubMedSearch : Sato_2026_J.Am.Med.Dir.Assoc_27_106481 |
| PubMedID: 42691804 |
| Title : Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-nave individuals with diabetes: A target trial emulation - Tatewaki_2026_Diabetes.Obes.Metab__ |
| Author(s) : Tatewaki T , Okada A , Kimura Y , Yasunaga H |
| Ref : Diabetes Obes Metab , : , 2026 |
| Abstract : |
| PubMedSearch : Tatewaki_2026_Diabetes.Obes.Metab__ |
| PubMedID: 41555834 |
| Title : Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study - Ohbe_2018_J.Med.Toxicol_14_237 |
| Author(s) : Ohbe H , Jo T , Matsui H , Fushimi K , Yasunaga H |
| Ref : J Med Toxicol , 14 :237 , 2018 |
| Abstract : |
| PubMedSearch : Ohbe_2018_J.Med.Toxicol_14_237 |
| PubMedID: 29907949 |